Dendritic Cells in Fundamental and Clinical Immunology

作者: Jacques Banchereau , Daniel Schmitt , Paola Ricciardi-Castagnoli , Paul Nieuwenhuis , Eduard W. A. Kamperdijk

DOI:

关键词:

摘要: Dendritic Cell Development and Migration.- Maturation.- Generation of Mature Cells from Human Blood.- Growth Differentiation CD34+ Progenitors.- Hematopoietic Progenitors Cord Blood Differentiate Along two Independent Pathways in Response to GM-CSF+TNF?.- Myeloid DCs Deduced Monocytes.- Dramatic Numerical Increase Functionally FLT3 Ligand-Treated Mice.- Selective Expression Fascin (p55) by Leukocytes.- Dendritic-Like relB Mutant Driving Gene Specifically Cells.- Checkpoints Functional Stages DC T Cell-Mediated Terminal Maturation cells.- Migration Cultured Chimpanzee Following Intravenous Subcutaneous Injection.- The Liver Sinusoids as a Specialized Site for Blood-Lymph Translocation Rat Regulation CD44 Isoform CD44-Mediated Signaling Mouse Spleen 3D-Collagen Lattices.- the Murine Peyer's Patches Colocalize with Salmonella Typhimurium Avirulent Mutants Subepithelial Dome.- Role CD11c+ Possible Candidates Immature Patches.- Influence Collagen, Fibronectin, Laminin on Propagated Normal or Flt3-Ligand-Treated Liver.- Stimulation Langerhans Mice Tumour Necrosis Factor ? Interleukin 1?.- Require Signals Both 1? ?6 Integrins are Required Modulation C5a Receptor (CD88) Skin Unilineage Cultures Generated Purified Progenitor CD14 is Expressed Subsets Upregulated Lipopolysaccharide.- TGF-?1 Dependent LAG+ Serum-Free Medium.- Antigen Uptake, Processing, Presentation.- A Newly Identified Retention Compartment FSDC Precursor Line.- Mannose Mediated Uptake Antigens Strongly Enhances HLA-Class II Restricted Presentation Mechanisms Fc?RI-IgE-Facilitated Allergen Localization Intracellular Transport MHC Class Molecules Bone Marrow-Derived Enhanced Presenting Function Vivo Priming.- Lacking Invariant Chain Express High Levels Membrane Vivo.- Lymphocyte Costimulator Molecule Activation Via Sialophorin (CD43).- Processing Exogenous Protein Cytotoxic Lymphocytes.- TH1 Lymphokine Interferon-? Potent Upregulator Phagocytic Capacity GM-CSF Supplemented Marrow Cultures.- CD101 Tetanus Toxoid Autologous Tolerance.- Responses Subpopulation CD8+DEC205+ Constructing Artificial Antigen-Presenting Drosophila Induction Tolerance Immunity B7-2+ Low Density APCS Effective B7-2? Small Resting B Inducing Specific Unresponsiveness Minor Histocompatibility (miH) Antigen(S) An Attempt Induce Infusion Donor Organ Allograft Recipients.- Blocking B7-CD28 Pathway Increases FasL+ (CD95L+) Kill Alloactivated Nitric Oxide Its Implications Immune Regulation.- Autoimmune Insulitis NOD Models Diabetes.- Inflammatory CNS.- Cytokine Networks.- Th-1/Th-2 Switch Inhaled Antigens.- TGF?1 Null Mouse.- Situ.- IL-12 Production IL-10 Prevents CD14+ Monocytes, Promotes Macrophages Stimulates Endocytosis FITC-dextran.- Dendritic/Langerhans Control CD40 Activated Surrogate Interactions Leads Costimulation, Secretion TH1-Associated Cytokines, CTL Inductive Capacity.- Soluble CD16/Fc?RIII Induces Several Cytokines Including IL-12.- Fc?RI? mRNA Synthesis 4 Cells-Derived Cd1a+ FACS-Sorted Patch Different Th0 Clones.- Cells, Obtained Peripheral Precursors Presence PGE2, Promote Th2 Responses.- Distinct Helper Populations Potential during Primary Response.- Viral Infections.- Immunogens Targets Cutaneous Replication Immunodeficiency Viruses.- Use Multiple HIV Coreceptors.- In Vitro Infection Precursors.- Lymph Nodes Analysed HIV-1 Life Cycle Blocked at Two Points Measles Virus Suppression.- Immortalized Lines Morphology Derived Type I Interferon Receptors Present Mixed Leukocyte Reactions.- Thymic Release Factor(s).- Molecular Specializations.- Surface Molecules.- Analysis Genetic Level.- Subtractive cDNA Cloning.- Increased Level Phosphotyrosine under Contact Sensitizers but Not Irritants.- Insulin-Like (IGF-I) Supports V-relER Differential Untreated TNF-? Elicited Stimulation.- Isolation Differentially Genes Epidermal Follicular Absence (FDC) Deficient TNF/Lymphotoxin (LT) Signaling.- CR2 FDC-B Interactions.- Disappearance Exchanging Ability FDC Induced Repeated Injections.- Adjuvants Therapy.- Priming Tumor-Associated Proteins.- Cell-Based Vaccines Cancer.- Immunotherapy Tumor-Infiltrating Defective Their Inducible B7 Expression.- Costimulation vivo.- Positive Negative Lipopolysaccharide Leishmaniasis Depleted Based Therapy Identification CD1a Putative Infiltrating Breast 12 Tumor-Specific Vaccines.- T-Cell E7 HER-2/Neu Oncogene Products Using Ex-Vivo Peptide Loaded Cells.

参考文章(0)